Clear Street’s CERo Therapeutics CERO Stock Holding History

Clear Street’s Portfolio CERO Stock Details CERO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-27	Closed	-$601K	–	850
2023 Q4	$601K	Sell	27 -10	-27%	-$218K	0.01%	56
2023 Q3	$797K	Sell	37 -59	-61%	-$1.28M	0.01%	108
2023 Q2	$2.08M	Buy	+96	New	+$2.08M	0.02%	227
2023 Q1	–	Hold	0	–	–	–	1147

Other funds holding CERO

AVM

Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return

HSG Holding Na, Hong Kong $1.62B AUM 5.91% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

KPWS

Kestra Private Wealth Services Austin, Texas $9.1B AUM 32.09% 1-Year Est. Return

Pineridge Advisors St. Charles, Missouri $350M AUM 6.38% 1-Year Est. Return

FIA

FNY Investment Advisers New York $278M AUM 98.99% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Clear Street's CERO Position: Q1 2024 in Review

Clear Street sold out of CERo Therapeutics (CERO) in Q1 2024, closing a stake of 27 shares — an estimated $601K sold.

Clear Street first reported a position in CERO in Q2 2023 and held it in 3 quarters. The position peaked at $2.08M in Q2 2023. 7 funds tracked by Wall St. Rank hold CERO as of Q1 2024.

Clear Street reported no remaining CERo Therapeutics position as of Q1 2024 after selling out during the quarter.
Clear Street sold 27 CERo Therapeutics shares in Q1 2024, an estimated $601K.
Clear Street first reported a position in CERo Therapeutics in Q2 2023 and held it in 3 quarters.
Clear Street's CERo Therapeutics position peaked at $2.08M in Q2 2023.
7 funds tracked by Wall St. Rank held CERo Therapeutics as of Q1 2024.

Based on Clear Street's 13F filing for Q1 2024, filed 13 May 2024.